Medical-Device Venture Capitalists Go To Washington (WSJ Blog)
Health care-focused venture capitalists have long been telling anyone on Capitol Hill who will listen that problems at the Food and Drug Administration are stifling innovation and deal flow, as they say the agency is inconsistent and vague on the rules for approving new medical technologies.
But a recent trip to Washington by a group of top life sciences investors – which calls itself the Medical Device Venture Council – showed that some power brokers inside the Beltway might be taking up the battle cry.
Some lawmakers – especial...
The Orthopedics Industry 
